نتایج جستجو برای: febrile neutropenia drug

تعداد نتایج: 606432  

Journal: :The Journal of antimicrobial chemotherapy 2006
Mical Paul Dafna Yahav Abigail Fraser Leonard Leibovici

OBJECTIVES Early, empirical broad-spectrum antibiotic treatment is the established practice for febrile neutropenia. Several beta-lactams are accepted for monotherapy. We asked whether patients' outcomes are influenced by the chosen beta-lactam. METHODS Systematic review and meta-analysis of randomized controlled trials comparing anti-pseudomonal beta-lactams administered as empirical monothe...

2012
Alpay Azap Gülden Yılmaz Bozkurt Meltem Kurt Yüksel Hakan Kutlu Pervin Topçuoğlu Adalet Aypak Hamdi Akan

OBJECTIVE Patients with neutropenia due to cancer chemotherapy are prone to severe infections. Cancer patients canexperience >1 infectious episode during the same period of neutropenia. This study aimed to determine the etiologicaland clinical characteristics of secondary infectious episodes in cancer patients with febrile neutropenia and to identifythe factors associated with the risk of secon...

2016
Roberto Guariglia Maria Carmen Martorelli Rosa Lerose Donatella Telesca Maria Rita Milella Pellegrino Musto

Neutropenia and febrile neutropenia (FN) are frequent and potentially fatal toxicities of myelosuppressive anticancer treatments. The introduction of granulocyte colony-stimulating factors (G-CSFs) in clinical practice has remarkably reduced the duration and severity of neutropenia, as well as the incidence of FN, thus allowing the administration of chemotherapeutic agents at the optimal dose a...

Journal: :Precision radiation oncology 2023

Abstract Neutropenia is the most common hematological toxicity of concurrent chemoradiotherapy (CCRT), and leads to subsequent treatment delays and/or dose reductions. often advances febrile neutropenia serious infections, which can affect prognosis safety patients. The reasonable prevention management vital for patients with malignancies undergoing CCRT. Pegylated recombinant human granulocyte...

2016
Giuseppe Di Lorenzo Sergio Bracarda Donatello Gasparro Angela Gernone Caterina Messina Vittorina Zagonel Livio Puglia Davide Bosso Davide Dondi Guru Sonpavde Giuseppe Lucarelli Sabino De Placido Carlo Buonerba Masaki Shiota.

Cabazitaxel provided a survival advantage compared with mitoxantrone in patients with castration-resistant prostate cancer refractory to docetaxel. Grade 3 to 4 (G3-4) neutropenia and febrile neutropenia were relatively frequent in the registrative XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (TROPIC) trial, but their incidenc...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2014
Xin-En Huang Jie Cao Zhi-Ying Qian Xia Xu Lin Shi Xue-Yan Wu Jin Liu Lin Wang

PURPOSE To investigate whether it is safe to use leucogen tablets 60 mg three times per day (180 mg for a day) and whether this regimen could reduce the incidence of febrile neutropenia caused by chemotherapy. METHODS This prospectively designed study focused on the safety and effectiveness of leucogen tablets 60mg three times per day for a group of cancer patients during chemotherapy for mai...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2017
H Inaba D Pei J Wolf S C Howard R T Hayden M Go O Varechtchouk T Hahn J Buaboonnam M L Metzger J E Rubnitz R C Ribeiro J T Sandlund S Jeha C Cheng W E Evans M V Relling C-H Pui

Background Comprehensive studies on neutropenia and infection-related complications in patients with acute lymphoblastic leukemia (ALL) are lacking. Patients and methods We evaluated infection-related complications that were grade ≥3 on National Cancer Institute's Common Terminology Criteria for Adverse Events (version 3.0) and their risk factors in 409 children with newly diagnosed ALL throu...

Background: Most frequently, empirical antibiotic therapy is immediately administered for patients with febrile neutropenia (FN). In this study, its aim was to assess the antibiotic resistance status and the cost of antibacterial agents in FN patients associated with hematological malignancies. Methods: The cost of antibacterial agents used in FN episodes in patients with hematologic neoplasms ...

Azadeh Eshraghi, Azita Hajhossein Talasaz Jamshid Salamzadeh, Maria Tavakoli-Ardakani

Drug Utilization Evaluation (DUE) studies facilitate assessing the appropriateness and rational use of medications.The goal of the present study was to evaluate Amphotericin B usage in neutropenic patients. A prospective DUE study was performed in Hematology-Oncology and Stem Cell Transplantation wards at Taleghani hospital for one-year. National comprehensive cancer network, clinical practice ...

2011
Jean-Philippe Lanoix Emilie Pluquet Francois Xavier Lescure Houcine Bentayeb Emmanuelle Lecuyer Marie Boutemy Patrick Dumont Vincent Jounieaux Jean Luc Schmit Charles Dayen Youcef Douadi

BACKGROUND The chemotherapy used to treat lung cancer causes febrile neutropenia in 10 to 40% of patients. Although most episodes are of undetermined origin, an infectious etiology can be suspected in 30% of cases. In view of the scarcity of data on lung cancer patients with febrile neutropenia, we performed a retrospective study of the microbiological characteristics of cases recorded in three...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید